Mechanisms of β-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 6, 1998, Pages 697-702

  Bonfiglio, Giovanni ^a   Laksai, Younes ^a   Franchino, Luigi ^b   Amicosante, Gianfranco ^c   Nicoletti, Giuseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Zeneca SpA   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBENICILLIN; CEFALORIDINE; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; IMIPENEM; MEROPENEM; NITROCEFIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; PORIN; TICARCILLIN; TIMENTIN; UREIDOPENICILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG TRANSPORT; ENZYME SYNTHESIS; ITALY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; DRUG RESISTANCE, MICROBIAL; HUMANS; ISOELECTRIC FOCUSING; ITALY; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 0032445066     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.6.697     Document Type: Article

References (22)

1. Stefani, S., Bonfiglio, G., Urzl̀, S. & Nicoletti, G. (1998). Susceptibility survey of piperacillin/tazobactam and some β-lactam comparators in Italy. Drugs Under Experimental and Clinical Research 24, 105-113.
2. Bonfiglio, G., Carciotto, V., Russo, G., Stefani, S., Debbia, E., Schito, G. C. et al. (1998). Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey. Journal of Antimicrobial Chemotherapy 41, 307-10.
3. National Committee for Clinical Laboratory Standards. (1990). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Second Edition: Approved Standard M7-A2. NCCLS, Villanova, PA.
4. Williams, R. J., Livermore, D. M., Lindridge, M. A., Said, A. A. & Williams, J. D. (1984). Mechanisms of β-lactam resistance in British isolates of Pseudomonas aeruginosa. Journal of Medical Microbiology 17, 283-93.
5. Akova, M., Bonfiglio, G. & Livermore, D. M. (1991). Susceptibility to β-lactam antibiotics of mutant strains of Xanthomonas maltophilia with high- and low-level constitutive expression of L-1 and L-2 β-lactamases. Journal of Medical Microbiology 35, 208-13.
6. O'Callaghan, C. H., Morris, A., Kirby, S. M. & Shingler, A. H. (1972). Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrobial Agents and Chemotherapy 1, 283-8.
7. Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951). Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193, 265-75.
8. Mathew, A., Harris, A. M., Marshall, M. J. & Ross, G. W. (1975). The use of analytical isoelectric focusing for detection and identification of β-lactamases. Journal of General Microbiology 88, 169-78.
9. Ambler, R. P. (1980). The structure of β-lactamases. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 289, 321-31.
10. Poole, K., Krebes, K., McNally, C. & Neshat, S. (1993). Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. Journal of Bacteriology 175, 7363-72.
11. Li, X.-Z., Ma, D., Livermore, D. M. & Nikaido, H. (1994). Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to β-lactam resistance. Antimicrobial Agents and Chemotherapy 38, 1742-52.
12. Chen, H. Y., Yuan, M. & Livermore, D. M. (1995). Mechanisms of resistance to β-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993. Journal of Medical Microbiology 43, 300-9.
13. 3. Curtis, N. A., Eisenstadt, R. L., Rudd, C. & White. A. J. (1986). Inducible type-I β-lactamase of Gram-negative bacteria and resistance to β-lactam antibiotics. Journal of Antimicrobial Chemotherapy 17, 51-61.
14. Bush, K. (1989). Characterisation of β-lactamases. Antimicrobial Agents and Chemotherapy 33, 259-63.
15. Bush, K. (1989). Classification of β-lactamases: group 1, 2a, 2b, and 2b'. Antimicrobial Agents and Chemotherapy 33, 264-70.
16. Bush, K. (1989). Classification of β-lactamases: groups 2c, 2d, 2e, 3 and 4. Antimicrobial Agents and Chemotherapy 33, 271-6.
17. Jacoby, G. A. & Sutton, L. (1979). Activity of β-lactam antibiotics against Pseudomonas aeruginosa carrying R-plasmids determining different β-lactamases. Antimicrobial Agents and Chemotherapy 16, 243-5.
18. Buscher, K. H., Cullmann, W., Dick, W. & Opferkuch, W. (1987). Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein. Antimicrobial Agents and Chemotherapy 31, 703-8.
19. Thabaut, A., Philippon, A. & Meyran, M. (1985). β-Lactamases of Pseudomonas aeruginosa and susceptibility against β-lactam antibiotics. Chemioterapia 4, 36-42.
20. Tirado, M., Roy, C., Segura, C., Reig, R., Hermida, M. & Foz, A. (1986). Incidence of strains producing plasmid determined β-lactamases among carbenicillin resistant Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 18, 453-8.
21. Sumita, Y., Fukasawa, M. & Okuda, T. (1987). SM-7338 a new carbapenem antibiotic: affinities for PBPs and morphological changes. In Program and Abstracts of the Twenty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, New York, 1987. Abstract 756, p. 228. American Society for Microbiology, Washington, DC.
22. Sumita, Y. & Fukasawa, M. (1996). Meropenem resistance in Pseudomonas aeruginosa. Chemotherapy 42, 47-56.